Insider SULIMAN SHEHNAAZ Sells 5,723 10X Genomics Class A Shares Amid 221% Year‑to‑Date Rally—Rule 10b‑5‑1 Plan, No Bearish Signal?
Insider SULIMAN SHEHNAAZ sold 5,359 shares of 10X Genomics, but it’s a routine Rule‑10b‑5‑1 move. Focus on the company’s oncology partnership and pipeline, not the modest sell‑off.
Target length: 140–160 characters.<|end|>
Target length: 140–160 characters.<|end|>
3 minutes to read